{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:19:11Z","timestamp":1783523951292,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-024-12037-1","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T08:58:37Z","timestamp":1734512317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Estimating the incremental population health impact of a multi-cancer early detection (MCED) test to complement existing screening among elevated risk populations with multiple cancer risk factors: a mathematical modeling study"],"prefix":"10.1186","volume":"24","author":[{"given":"Ashley","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Rahman","family":"Jazieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Fryzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"12037_CR1","unstructured":"Ortman JM, Velkoff, VA, Hogan, H. An aging nation: The older population in the United States. U.S. Census Bureau. Available from: https:\/\/www.census.gov\/library\/publications\/2014\/demo\/p25-1140.html. Accessed 2 Oct 2023. Cited 8 Dec 2021."},{"key":"12037_CR2","doi-asserted-by":"publisher","DOI":"10.5888\/pcd18.210006","volume":"18","author":"HK Weir","year":"2021","unstructured":"Weir HK, Thompson TD, Stewart SL, White MC. Cancer incidence projections in the United States between 2015 and 2050. Prev Chronic Dis. 2021;18: 210006.","journal-title":"Prev Chronic Dis"},{"key":"12037_CR3","unstructured":"Mendes E. More than 4 in 10 cancers and cancer deaths linked to modifiable risk factors. American Cancer Society. Available from: https:\/\/www.cancer.org\/research\/acs-research-news\/more-than-4-in-10-cancers-and-cancer-deaths-linked-to-modifiable-risk-factors.html. Accessed 2 Oct 2023. Cited 8 Dec 2021."},{"key":"12037_CR4","volume-title":"Cancer prevention and early detection facts & figures 2019\u20132020","author":"American Cancer Society","year":"2019","unstructured":"American Cancer Society. Cancer prevention and early detection facts & figures 2019\u20132020. Atlanta: American Cancer Society; 2019."},{"key":"12037_CR5","unstructured":"National Cancer Institute. The genetics of cancer. Available from: https:\/\/www.cancer.gov\/about-cancer\/causesprevention\/genetics. Accessed 2 Oct 2023. Cited 2023 May 26."},{"issue":"4","key":"12037_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886","volume":"164","author":"AL Siu","year":"2016","unstructured":"Siu AL. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(4):279\u201396.","journal-title":"Ann Intern Med."},{"key":"12037_CR7","doi-asserted-by":"crossref","unstructured":"Curry SJ, Krist AH, Owens DK, et al. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. JAMA. 2018;320(7):674\u201386.","DOI":"10.1001\/jama.2018.10897"},{"key":"12037_CR8","doi-asserted-by":"crossref","unstructured":"Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for colorectal cancer: an evidence update for the U.S. Preventive Services Task Force. 2021. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK570913\/.","DOI":"10.1001\/jama.2021.4417"},{"key":"12037_CR9","doi-asserted-by":"crossref","unstructured":"Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP, et al. Screening for lung cancer with low-dose computed tomography: an evidence review for the U.S. Preventive Services Task Force. 2021. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK568573\/.","DOI":"10.1001\/jama.2021.0377"},{"issue":"18","key":"12037_CR10","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2018.3710","volume":"319","author":"DC Grossman","year":"2018","unstructured":"Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, et al. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. JAMA. 2018;319(18):1901\u201313.","journal-title":"JAMA."},{"key":"12037_CR11","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Limited-Field Data, 22 Registries, Nov 2021 Sub (2000\u20132019) - Linked To County Attributes - Time Dependent (1990\u20132019) Income\/Rurality, 1969\u20132020 Counties. National Cancer Institute, DCCPS, Surveillance Research Program; released April 2022, based on the November 2021 submission."},{"issue":"4","key":"12037_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ccell.2021.02.004","volume":"39","author":"CA Clarke","year":"2021","unstructured":"Clarke CA, Hubbell E, Ofman JJ. Multi-cancer early detection: A new paradigm for reducing cancer-specific and all-cause mortality. Cancer Cell. 2021;39(4):447\u20138.","journal-title":"Cancer Cell"},{"key":"12037_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.102046","volume":"30","author":"A Kim","year":"2022","unstructured":"Kim A, Gitlin M, Fadli E, McGarvey N, Cong Z, Chung KC. Breast, Colorectal, Lung, Prostate, and Cervical Cancer Screening Prevalence in a Large Commercial and Medicare Advantage Plan, 2008\u20132020. Prev Med Rep. 2022;30: 102046.","journal-title":"Prev Med Rep"},{"issue":"1","key":"12037_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21440","volume":"68","author":"F Islami","year":"2018","unstructured":"Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31\u201354.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"12037_CR15","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/s41416-021-01498-4","volume":"125","author":"A Hackshaw","year":"2021","unstructured":"Hackshaw A, Cohen SS, Reichert H, Kansal AR, Chung KC, Ofman JJ. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. Br J Cancer. 2021;125(10):1432\u201342.","journal-title":"Br J Cancer"},{"issue":"9","key":"12037_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","volume":"32","author":"EA Klein","year":"2021","unstructured":"Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167\u201377.","journal-title":"Ann Oncol"},{"key":"12037_CR17","unstructured":"Division of Cancer Prevention and Control. Risk factors and cancer. Available from: https:\/\/www.cdc.gov\/cancer\/risk-factors\/index.html. Accessed 2 Oct 2023."},{"issue":"8","key":"12037_CR18","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1093\/jnci\/djaa170","volume":"113","author":"SA Fedewa","year":"2021","unstructured":"Fedewa SA, Kazerooni EA, Studts JL, Smith RA, Bandi P, Sauer AG, et al. State variation in low-dose computed tomography scanning for lung cancer screening in the United States. J Natl Cancer Inst. 2021;113(8):1044\u201352.","journal-title":"J Natl Cancer Inst"},{"key":"12037_CR19","unstructured":"National Center for Chronic Disease Prevention and Health Promotion. DoPH. Compliance from BRFSS prevalence and trends data. 2020. Available from: https:\/\/www.cdc.gov\/brfss\/brfssprevalence\/."},{"issue":"1","key":"12037_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/gim.2011.2","volume":"14","author":"CC Teerlink","year":"2012","unstructured":"Teerlink CC, Albright FS, Lins L, Cannon-Albright LA. A comprehensive survey of cancer risks in extended families. Genet Med. 2012;14(1):107\u201314.","journal-title":"Genet Med"},{"issue":"3","key":"12037_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/0969141315579119","volume":"22","author":"PF Pinsky","year":"2015","unstructured":"Pinsky PF, Zhu CS, Kramer BS. Lung cancer risk by years since quitting in 30+ pack year smokers. J Med Screen. 2015;22(3):151\u20137.","journal-title":"J Med Screen"},{"key":"12037_CR22","unstructured":"National Center for Chronic Disease Prevention and Health Promotion. DoPH. Compliance from BRFSS prevalence and trends data. 2015. Available from: https:\/\/www.cdc.gov\/brfss\/brfssprevalence\/. Cited 26 Feb 2019."},{"key":"12037_CR23","unstructured":"Hoffman RM. Screening for prostate cancer. UpToDate. [cited 16 January 2019]. Available from: https:\/\/www.uptodate.com\/contents\/screening-for-prostate-cancer. Accessed 2 Oct 2023."},{"issue":"3","key":"12037_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.2530","volume":"5","author":"CI Liao","year":"2022","unstructured":"Liao CI, Francoeur AA, Kapp DS, Caesar MAP, Huh WK, Chan JK. Trends in human papillomavirus-associated cancers, demographic characteristics, and vaccinations in the US, 2001\u20132017. JAMA Netw Open. 2022;5(3): e222530.","journal-title":"JAMA Netw Open"},{"issue":"30","key":"12037_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.102046","volume":"12","author":"A Kim","year":"2022","unstructured":"Kim A, Gitlin M, Fadli E, McGarvey N, Cong Z, Chung KC. Breast, colorectal, lung, prostate, and cervical cancer screening prevalence in a large commercial and Medicare Advantage Plan, 2008\u20132020. Prev Med Rep. 2022;12(30): 102046.","journal-title":"Prev Med Rep"},{"issue":"2","key":"12037_CR26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.chest.2021.07.030","volume":"161","author":"SA Fedewa","year":"2022","unstructured":"Fedewa SA, Bandi P, Smith RA, Silvestri GA, Jemal A. Lung cancer screening rates during the COVID-19 pandemic. Chest. 2022;161(2):586\u20139.","journal-title":"Chest"},{"key":"12037_CR27","doi-asserted-by":"crossref","unstructured":"Schrag D, Beer TM, McDonnell III CH, Nadauld L, Dilaveri CA, Klein EA, et al. Evaluation of anxiety, distress and satisfaction using a multi-cancer early detection (MCED) test. Poster presented at European Society of Medical Oncology Annual Meeting, September 11, 2022. Paris, France. Available from: https:\/\/grail.com\/wp-content\/uploads\/2022\/09\/Schrag_908P_ESMO-2022_Pathfinder-PROs_Poster_Final.pdf.","DOI":"10.1016\/j.annonc.2022.07.1034"},{"key":"12037_CR28","unstructured":"Schrag D, Beer TM, McDonnell III CH, Nadauld L, Dilaveri CA, Klein EA, et al. Evaluation of anxiety, distress and satisfaction using a multi-cancer early detection (MCED) test. Poster presented at Early Detection of Cancer Conference, October 18\u201320, 2022. Portland, OR. Available from: https:\/\/grail.com\/wp-content\/uploads\/2022\/10\/Schrag_EDCC-2022_Pathfinder-PROs_Poster_Final.pdf."},{"issue":"7","key":"12037_CR29","doi-asserted-by":"publisher","first-page":"S551","DOI":"10.1016\/j.jval.2022.04.1402","volume":"25","author":"L Matza","year":"2022","unstructured":"Matza L, Howell TA, Fung E, Janes S, Seiden M, Hackshaw A, et al. PCR57 assessment of health state utilities associated with false-positive cancer screening results. Value in Health. 2022;25(7):S551.","journal-title":"Value in Health"},{"key":"12037_CR30","doi-asserted-by":"crossref","unstructured":"Matza LS, Howell TA, Fung E, Janes S, Seiden M, Hackshaw A, et al. Pilot study for assessment of health state utilities associated with false-positive cancer screening results. Poster presented at Academy of Managed Care Pharmacy (AMCP) 2022 Annual Meeting, March 29-April 1, 2022. Chicago, IL.","DOI":"10.1016\/j.jval.2021.11.1181"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-12037-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-024-12037-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-12037-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T09:06:26Z","timestamp":1734512786000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-024-12037-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12037"],"URL":"https:\/\/doi.org\/10.1186\/s12913-024-12037-1","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"21 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AK and ZC are employees of GRAIL, Inc. HR, GN, JF, and SSC were EpidStrategies employees at the time of publication. EpidStrategies received financial support from GRAIL, Inc to develop this manuscript. No disclosures were reported by the other authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1584"}}